{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:14:50Z","timestamp":1790493290524,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":69,"publisher":"Springer US","isbn-type":[{"value":"9781071612361","type":"print"},{"value":"9781071612378","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1237-8_9","type":"book-chapter","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T21:02:40Z","timestamp":1611262960000},"page":"149-178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Characterization and Activation of Fas Ligand-Producing Mouse B Cells and Their Killer Exosomes"],"prefix":"10.1007","author":[{"given":"Steven K.","family":"Lundy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophina H.","family":"Taitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luci\u00ebn E. P. M.","family":"van der Vlugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"issue":"1","key":"9_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.159.1.1","volume":"159","author":"JB Roths","year":"1984","unstructured":"Roths JB, Murphy ED, Eicher EM (1984) A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H\/HeJ mice. J Exp Med 159(1):1\u201320","journal-title":"J Exp Med"},{"issue":"10","key":"9_CR2","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/intimm\/5.10.1275","volume":"5","author":"ES Sobel","year":"1993","unstructured":"Sobel ES, Kakkanaiah VN, Cohen PL, Eisenberg RA (1993) Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene. Int Immunol 5(10):1275\u20131278","journal-title":"Int Immunol"},{"issue":"2","key":"9_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/1074-7613(94)90106-6","volume":"1","author":"DH Lynch","year":"1994","unstructured":"Lynch DH, Watson ML, Alderson MR, Baum PR, Miller RE, Tough T, Gibson M, Davis-Smith T, Smith CA, Hunter K et al (1994) The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1(2):131\u2013136","journal-title":"Immunity"},{"issue":"6","key":"9_CR4","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0092-8674(94)90375-1","volume":"76","author":"T Takahashi","year":"1994","unstructured":"Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76(6):969\u2013976","journal-title":"Cell"},{"issue":"9","key":"9_CR5","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1093\/intimm\/7.9.1381","volume":"7","author":"M Hahne","year":"1995","unstructured":"Hahne M, Peitsch MC, IrmLer M, Schroter M, Lowin B, Rousseau M, Bron C, Renno T, French L, Tschopp J (1995) Characterization of the non-functional Fas ligand of gld mice. Int Immunol 7(9):1381\u20131386","journal-title":"Int Immunol"},{"issue":"5","key":"9_CR6","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1073\/pnas.90.5.1756","volume":"90","author":"M Adachi","year":"1993","unstructured":"Adachi M, Watanabe-Fukunaga R, Nagata S (1993) Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci U S A 90(5):1756\u20131760","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9_CR7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1084\/jem.178.2.461","volume":"178","author":"J Wu","year":"1993","unstructured":"Wu J, Zhou T, He J, Mountz JD (1993) Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 178(2):461\u2013468","journal-title":"J Exp Med"},{"issue":"1","key":"9_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0167-5699(95)80069-7","volume":"16","author":"S Nagata","year":"1995","unstructured":"Nagata S, Suda T (1995) Fas and Fas ligand: lpr and gld mutations. Immunol Today 16(1):39\u201343","journal-title":"Immunol Today"},{"issue":"6","key":"9_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","volume":"81","author":"GH Fisher","year":"1995","unstructured":"Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81(6):935\u2013946","journal-title":"Cell"},{"issue":"5215","key":"9_CR10","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1126\/science.7539157","volume":"268","author":"F Rieux-Laucat","year":"1995","unstructured":"Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268(5215):1347\u20131349","journal-title":"Science"},{"issue":"5","key":"9_CR11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jpeds.2005.09.025","volume":"147","author":"JJ Bleesing","year":"2005","unstructured":"Bleesing JJ (2005) Sorting out the causes of ALPS. J Pediatr 147(5):571\u2013574. https:\/\/doi.org\/10.1016\/j.jpeds.2005.09.025","journal-title":"J Pediatr"},{"issue":"5","key":"9_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0022-3476(98)70102-7","volume":"133","author":"AJ Infante","year":"1998","unstructured":"Infante AJ, Britton HA, DeNapoli T, Middelton LA, Lenardo MJ, Jackson CE, Wang J, Fleisher T, Straus SE, Puck JM (1998) The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis. J Pediatr 133(5):629\u2013633","journal-title":"J Pediatr"},{"issue":"2","key":"9_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1172\/JCI115867","volume":"90","author":"MC Sneller","year":"1992","unstructured":"Sneller MC, Straus SE, Jaffe ES, Jaffe JS, Fleisher TA, Stetler-Stevenson M, Strober W (1992) A novel lymphoproliferative\/autoimmune syndrome resembling murine lpr\/gld disease. J Clin Invest 90(2):334\u2013341. https:\/\/doi.org\/10.1172\/JCI115867","journal-title":"J Clin Invest"},{"issue":"13","key":"9_CR14","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1182\/blood-2008-09-179630","volume":"113","author":"A Magerus-Chatinet","year":"2009","unstructured":"Magerus-Chatinet A, Stolzenberg MC, Loffredo MS, Neven B, Schaffner C, Ducrot N, Arkwright PD, Bader-Meunier B, Barbot J, Blanche S, Casanova JL, Debre M, Ferster A, Fieschi C, Florkin B, Galambrun C, Hermine O, Lambotte O, Solary E, Thomas C, Le Deist F, Picard C, Fischer A, Rieux-Laucat F (2009) FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha\/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function. Blood 113(13):3027\u20133030. https:\/\/doi.org\/10.1182\/blood-2008-09-179630","journal-title":"Blood"},{"issue":"1","key":"9_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1046\/j.1537-2995.2001.41010018.x","volume":"41","author":"DF Stroncek","year":"2001","unstructured":"Stroncek DF, Carter LB, Procter JL, Dale JK, Straus SE (2001) RBC autoantibodies in autoimmune lymphoproliferative syndrome. Transfusion 41(1):18\u201323","journal-title":"Transfusion"},{"issue":"5","key":"9_CR16","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1172\/JCI118892","volume":"98","author":"J Wu","year":"1996","unstructured":"Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 98(5):1107\u20131113","journal-title":"J Clin Invest"},{"issue":"1","key":"9_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/1529-0131(200001)43:1<135::AID-ANR17>3.0.CO;2-Q","volume":"43","author":"T Kojima","year":"2000","unstructured":"Kojima T, Horiuchi T, Nishizaka H, Sawabe T, Higuchi M, Harashima SI, Yoshizawa S, Tsukamoto H, Nagasawa K, Niho Y (2000) Analysis of fas ligand gene mutation in patients with systemic lupus erythematosus. Arthritis Rheum 43(1):135\u2013139","journal-title":"Arthritis Rheum"},{"issue":"3\u20134","key":"9_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1615\/CritRevImmunol.v15.i3-4.90","volume":"15","author":"EA Atkinson","year":"1995","unstructured":"Atkinson EA, Bleackley RC (1995) Mechanisms of lysis by cytotoxic T cells. Crit Rev Immunol 15(3\u20134):359\u2013384","journal-title":"Crit Rev Immunol"},{"issue":"7","key":"9_CR19","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.4049\/jimmunol.157.7.2909","volume":"157","author":"Y Oshimi","year":"1996","unstructured":"Oshimi Y, Oda S, Honda Y, Nagata S, Miyazaki S (1996) Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol 157(7):2909\u20132915","journal-title":"J Immunol"},{"issue":"3","key":"9_CR20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/eji.1830260332","volume":"26","author":"M Hahne","year":"1996","unstructured":"Hahne M, Renno T, Schroeter M, IrmLer M, French L, Bornard T, MacDonald HR, Tschopp J (1996) Activated B cells express functional Fas ligand. Eur J Immunol 26(3):721\u2013724","journal-title":"Eur J Immunol"},{"issue":"7","key":"9_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00011-009-0014-x","volume":"58","author":"SK Lundy","year":"2009","unstructured":"Lundy SK (2009) Killer B lymphocytes: the evidence and the potential. Inflammation Research 58(7):345\u2013357. https:\/\/doi.org\/10.1007\/s00011-009-0014-x","journal-title":"Inflammation Research"},{"issue":"1","key":"9_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1128\/IAI.69.1.271-280.2001","volume":"69","author":"SK Lundy","year":"2001","unstructured":"Lundy SK, Lerman SP, Boros DL (2001) Soluble egg antigen-stimulated T helper lymphocyte apoptosis and evidence for cell death mediated by FasL(+) T and B cells during murine Schistosoma mansoni infection. Infect Immun 69(1):271\u2013280","journal-title":"Infect Immun"},{"issue":"2","key":"9_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1128\/IAI.70.2.812-819.2002","volume":"70","author":"SK Lundy","year":"2002","unstructured":"Lundy SK, Boros DL (2002) Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10. Infect Immun 70(2):812\u2013819","journal-title":"Infect Immun"},{"issue":"12","key":"9_CR24","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s00011-005-1387-0","volume":"54","author":"SK Lundy","year":"2005","unstructured":"Lundy SK, Berlin AA, Martens TF, Lukacs NW (2005) Deficiency of regulatory B cells increases allergic airway inflammation. Inflammation Research 54(12):514\u2013521. https:\/\/doi.org\/10.1007\/s00011-005-1387-0","journal-title":"Inflammation Research"},{"issue":"4","key":"9_CR25","doi-asserted-by":"publisher","first-page":"R128","DOI":"10.1186\/ar2795","volume":"11","author":"SK Lundy","year":"2009","unstructured":"Lundy SK, Fox DA (2009) Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis. Arthritis Res Ther 11(4):R128. https:\/\/doi.org\/10.1186\/ar2795","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"9_CR26","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.4049\/jimmunol.167.2.1081","volume":"167","author":"J Tian","year":"2001","unstructured":"Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL (2001) Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 167(2):1081\u20131089","journal-title":"J Immunol"},{"issue":"24","key":"9_CR27","doi-asserted-by":"publisher","first-page":"E2199","DOI":"10.1073\/pnas.1222446110","volume":"110","author":"R Montandon","year":"2013","unstructured":"Montandon R, Korniotis S, Layseca-Espinosa E, Gras C, Megret J, Ezine S, Dy M, Zavala F (2013) Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells. Proc Natl Acad Sci U S A 110(24):E2199\u2013E2208. https:\/\/doi.org\/10.1073\/pnas.1222446110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"9_CR28","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1189\/jlb.0904536","volume":"78","author":"D Bonardelle","year":"2005","unstructured":"Bonardelle D, Benihoud K, Kiger N, Bobe P (2005) B lymphocytes mediate Fas-dependent cytotoxicity in MRL\/lpr mice. J Leukoc Biol 78(5):1052\u20131059. https:\/\/doi.org\/10.1189\/jlb.0904536","journal-title":"J Leukoc Biol"},{"issue":"8","key":"9_CR29","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.4049\/jimmunol.168.8.3965","volume":"168","author":"E Zuniga","year":"2002","unstructured":"Zuniga E, Motran CC, Montes CL, Yagita H, Gruppi A (2002) Trypanosoma cruzi infection selectively renders parasite-specific IgG+ B lymphocytes susceptible to Fas\/Fas ligand-mediated fratricide. J Immunol 168(8):3965\u20133973","journal-title":"J Immunol"},{"issue":"6","key":"9_CR30","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/01.tp.0000129799.96439.6f","volume":"78","author":"R Minagawa","year":"2004","unstructured":"Minagawa R, Okano S, Tomita Y, Kishihara K, Yamada H, Nomoto K, Shimada M, Maehara Y, Sugimachi K, Yoshikai Y, Nomoto K (2004) The critical role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen. Transplantation 78(6):799\u2013806. https:\/\/doi.org\/10.1097\/01.tp.0000129799.96439.6f","journal-title":"Transplantation"},{"issue":"5239","key":"9_CR31","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","volume":"270","author":"TS Griffith","year":"1995","unstructured":"Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270(5239):1189\u20131192","journal-title":"Science"},{"issue":"4","key":"9_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1006\/exer.1997.0371","volume":"65","author":"RR Mohan","year":"1997","unstructured":"Mohan RR, Liang Q, Kim WJ, Helena MC, Baerveldt F, Wilson SE (1997) Apoptosis in the cornea: further characterization of Fas\/Fas ligand system. Exp Eye Res 65(4):575\u2013589","journal-title":"Exp Eye Res"},{"issue":"3","key":"9_CR33","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1172\/JCI119173","volume":"99","author":"PM Stuart","year":"1997","unstructured":"Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA (1997) CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 99(3):396\u2013402","journal-title":"J Clin Invest"},{"issue":"9","key":"9_CR34","first-page":"1590","volume":"39","author":"A Jorgensen","year":"1998","unstructured":"Jorgensen A, Wiencke AK, la Cour M, Kaestel CG, Madsen HO, Hamann S, Lui GM, Scherfig E, Prause JU, Svejgaard A, Odum N, Nissen MH, Ropke C (1998) Human retinal pigment epithelial cell-induced apoptosis in activated T cells. Invest Ophthalmol Vis Sci 39(9):1590\u20131599","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"9_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/107155760200900411","volume":"9","author":"E Sapi","year":"2002","unstructured":"Sapi E, Brown WD, Aschkenazi S, Lim C, Munoz A, Kacinski BM, Rutherford T, Mor G (2002) Regulation of Fas ligand expression by estrogen in normal ovary. J Soc Gynecol Investig 9(4):243\u2013250","journal-title":"J Soc Gynecol Investig"},{"issue":"2","key":"9_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3109\/09273949709085055","volume":"5","author":"H Li","year":"1997","unstructured":"Li H, Ren J, Dhabuwala CB, Shichi H (1997) Immunotolerance induced by intratesticular antigen priming: expression of TGF-beta, Fas and Fas ligand. Ocul Immunol Inflamm 5(2):75\u201384","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"9_CR37","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/molehr\/3.8.655","volume":"3","author":"D Uckan","year":"1997","unstructured":"Uckan D, Steele A, Cherry WBY, Chamizo W, Koutsonikolis A, Gilbert-Barness E, Good RA (1997) Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion. Mol Hum Reprod 3(8):655\u2013662. https:\/\/doi.org\/10.1093\/molehr\/3.8.655","journal-title":"Mol Hum Reprod"},{"issue":"6","key":"9_CR38","first-page":"2188","volume":"84","author":"SW Kauma","year":"1999","unstructured":"Kauma SW, Huff TF, Hayes N, Nilkaeo A (1999) Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. J Clin Endocrinol Metab 84(6):2188\u20132194","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9_CR39","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1182\/blood.V97.5.1155","volume":"97","author":"F Silvestris","year":"2001","unstructured":"Silvestris F, Tucci M, Cafforio P, Dammacco F (2001) Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression. Blood 97(5):1155\u20131164","journal-title":"Blood"},{"issue":"11","key":"9_CR40","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1182\/blood.V91.11.4273","volume":"91","author":"I Tinhofer","year":"1998","unstructured":"Tinhofer I, Marschitz I, Kos M, Henn T, Egle A, Villunger A, Greil R (1998) Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1\/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia. Blood 91(11):4273\u20134281","journal-title":"Blood"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/400_2008_21","volume":"49","author":"M Lettau","year":"2009","unstructured":"Lettau M, Paulsen M, Kabelitz D, Janssen O (2009) FasL expression and reverse signalling. Results Probl Cell Differ 49:49\u201361. https:\/\/doi.org\/10.1007\/400_2008_21","journal-title":"Results Probl Cell Differ"},{"issue":"1","key":"9_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/sj.cdd.4401179","volume":"10","author":"MM Kavurma","year":"2003","unstructured":"Kavurma MM, Khachigian LM (2003) Signaling and transcriptional control of Fas ligand gene expression. Cell Death Differ 10(1):36\u201344","journal-title":"Cell Death Differ"},{"issue":"7","key":"9_CR43","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.4049\/jimmunol.164.7.3512","volume":"164","author":"WA Chow","year":"2000","unstructured":"Chow WA, Fang JJ, Yee JK (2000) The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells. J Immunol 164(7):3512\u20133518","journal-title":"J Immunol"},{"issue":"26","key":"9_CR44","doi-asserted-by":"publisher","first-page":"20281","DOI":"10.1074\/jbc.M110.109207","volume":"285","author":"D Sayed","year":"2010","unstructured":"Sayed D, He M, Hong C, Gao S, Rane S, Yang Z, Abdellatif M (2010) MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem 285(26):20281\u201320290. https:\/\/doi.org\/10.1074\/jbc.M110.109207","journal-title":"J Biol Chem"},{"issue":"8","key":"9_CR45","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.4049\/jimmunol.161.8.3943","volume":"161","author":"JH Li","year":"1998","unstructured":"Li JH, Rosen D, Ronen D, Behrens CK, Krammer PH, Clark WR, Berke G (1998) The regulation of CD95 ligand expression and function in CTL. J Immunol 161(8):3943\u20133949","journal-title":"J Immunol"},{"issue":"Pt 1","key":"9_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1242\/jcs.03315","volume":"120","author":"E Zuccato","year":"2007","unstructured":"Zuccato E, Blott EJ, Holt O, Sigismund S, Shaw M, Bossi G, Griffiths GM (2007) Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation. J Cell Sci 120(Pt 1):191\u2013199. https:\/\/doi.org\/10.1242\/jcs.03315","journal-title":"J Cell Sci"},{"issue":"2","key":"9_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1046\/j.1423-0410.1998.7420113.x","volume":"74","author":"M Mincheff","year":"1998","unstructured":"Mincheff M, Loukinov D, Zoubak S, Hammett M, Meryman H (1998) Fas and Fas ligand expression on human peripheral blood leukocytes. Vox Sang 74(2):113\u2013121","journal-title":"Vox Sang"},{"issue":"3","key":"9_CR48","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.4049\/jimmunol.163.3.1274","volume":"163","author":"MJ Martinez-Lorenzo","year":"1999","unstructured":"Martinez-Lorenzo MJ, Anel A, Gamen S, Monle NI, Lasierra P, Larrad L, Pineiro A, Alava MA, Naval J (1999) Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J Immunol 163(3):1274\u20131281","journal-title":"J Immunol"},{"issue":"43","key":"9_CR49","doi-asserted-by":"publisher","first-page":"39938","DOI":"10.1074\/jbc.M107005200","volume":"276","author":"S Jodo","year":"2001","unstructured":"Jodo S, Xiao S, Hohlbaum A, Strehlow D, Marshak-Rothstein A, Ju ST (2001) Apoptosis-inducing membrane vesicles. A novel agent with unique properties. J Biol Chem 276(43):39938\u201339944. https:\/\/doi.org\/10.1074\/jbc.M107005200","journal-title":"J Biol Chem"},{"issue":"5\u20136","key":"9_CR50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1600-0897.2006.00435.x","volume":"56","author":"A Sabapatha","year":"2006","unstructured":"Sabapatha A, Gercel-Taylor C, Taylor DD (2006) Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol 56(5\u20136):345\u2013355. https:\/\/doi.org\/10.1111\/j.1600-0897.2006.00435.x","journal-title":"Am J Reprod Immunol"},{"issue":"2","key":"9_CR51","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.exer.2005.11.028","volume":"83","author":"NM McKechnie","year":"2006","unstructured":"McKechnie NM, King BC, Fletcher E, Braun G (2006) Fas-ligand is stored in secretory lysosomes of ocular barrier epithelia and released with microvesicles. Exp Eye Res 83(2):304\u2013314. https:\/\/doi.org\/10.1016\/j.exer.2005.11.028","journal-title":"Exp Eye Res"},{"issue":"7","key":"9_CR52","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nm0797-738","volume":"3","author":"SM Kang","year":"1997","unstructured":"Kang SM, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG, Baekkeskov S (1997) Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med 3(7):738\u2013743","journal-title":"Nat Med"},{"issue":"1","key":"9_CR53","doi-asserted-by":"publisher","first-page":"518","DOI":"10.4049\/jimmunol.162.1.518","volume":"162","author":"T Takeuchi","year":"1999","unstructured":"Takeuchi T, Ueki T, Nishimatsu H, Kajiwara T, Ishida T, Jishage K, Ueda O, Suzuki H, Li B, Moriyama N, Kitamura T (1999) Accelerated rejection of Fas ligand-expressing heart grafts. J Immunol 162(1):518\u2013522","journal-title":"J Immunol"},{"issue":"5","key":"9_CR54","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.4049\/jimmunol.169.5.2727","volume":"169","author":"MS Gregory","year":"2002","unstructured":"Gregory MS, Repp AC, Holhbaum AM, Saff RR, Marshak-Rothstein A, Ksander BR (2002) Membrane Fas ligand activates innate immunity and terminates ocular immune privilege. J Immunol 169(5):2727\u20132735","journal-title":"J Immunol"},{"issue":"8","key":"9_CR55","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1002\/eji.1830250828","volume":"25","author":"SM Mariani","year":"1995","unstructured":"Mariani SM, Matiba B, BaumLer C, Krammer PH (1995) Regulation of cell surface APO-1\/Fas (CD95) ligand expression by metalloproteases. Eur J Immunol 25(8):2303\u20132307","journal-title":"Eur J Immunol"},{"issue":"24","key":"9_CR56","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/S0960-9822(00)80113-X","volume":"9","author":"WC Powell","year":"1999","unstructured":"Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM (1999) The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 9(24):1441\u20131447","journal-title":"Curr Biol"},{"issue":"4","key":"9_CR57","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1006\/exer.2002.2044","volume":"75","author":"Y Sano","year":"2002","unstructured":"Sano Y, Yamada J, Ishino Y, Adachi W, Kawasaki S, Suzuki T, Kinoshita S, Okuyama T, Azuma N (2002) Non-cleavable mutant Fas ligand transfection of donor cornea abrogates ocular immune privilege. Exp Eye Res 75(4):475\u2013483","journal-title":"Exp Eye Res"},{"key":"9_CR58","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fimmu.2015.00122","volume":"6","author":"SK Lundy","year":"2015","unstructured":"Lundy SK, Klinker MW, Fox DA (2015) Killer B lymphocytes and their fas ligand positive exosomes as inducers of immune tolerance. Front Immunol 6:122. https:\/\/doi.org\/10.3389\/fimmu.2015.00122","journal-title":"Front Immunol"},{"issue":"8","key":"9_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070131","volume":"8","author":"MW Klinker","year":"2013","unstructured":"Klinker MW, Reed TJ, Fox DA, Lundy SK (2013) Interleukin-5 supports the expansion of Fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4(+) T cells and secrete Interleukin-10. PLoS One 8(8):e70131. https:\/\/doi.org\/10.1371\/journal.pone.0070131","journal-title":"PLoS One"},{"issue":"2","key":"9_CR60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0952-7915(00)00204-1","volume":"13","author":"F Martin","year":"2001","unstructured":"Martin F, Kearney JF (2001) B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol 13(2):195\u2013201","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"9_CR61","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1073\/pnas.0700001104","volume":"104","author":"Y Yang","year":"2007","unstructured":"Yang Y, Tung JW, Ghosn EE, Herzenberg LA, Herzenberg LA (2007) Division and differentiation of natural antibody-producing cells in mouse spleen. Proc Natl Acad Sci U S A 104(11):4542\u20134546. https:\/\/doi.org\/10.1073\/pnas.0700001104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/intimm\/7.1.55","volume":"7","author":"AB Kantor","year":"1995","unstructured":"Kantor AB, Stall AM, Adams S, Watanabe K, Herzenberg LA (1995) De novo development and self-replenishment of B cells. Int Immunol 7(1):55\u201368","journal-title":"Int Immunol"},{"issue":"4","key":"9_CR63","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1073\/pnas.1015841108","volume":"108","author":"M Yoshimoto","year":"2011","unstructured":"Yoshimoto M, Montecino-Rodriguez E, Ferkowicz MJ, Porayette P, Shelley WC, Conway SJ, Dorshkind K, Yoder MC (2011) Embryonic day 9 yolk sac and intra-embryonic hemogenic endothelium independently generate a B-1 and marginal zone progenitor lacking B-2 potential. Proc Natl Acad Sci U S A 108(4):1468\u20131473. https:\/\/doi.org\/10.1073\/pnas.1015841108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR64","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2119\/molmed.2011.00333","volume":"18","author":"MW Klinker","year":"2012","unstructured":"Klinker MW, Lundy SK (2012) Multiple mechanisms of immune suppression by B lymphocytes. Mol Med 18:123\u2013137. https:\/\/doi.org\/10.2119\/molmed.2011.00333","journal-title":"Mol Med"},{"issue":"7","key":"9_CR65","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/jgm.730","volume":"7","author":"Y Morita","year":"2005","unstructured":"Morita Y, Gupta R, Seidl KM, McDonagh KT, Fox DA (2005) Cytokine production by dendritic cells genetically engineered to express IL-4: induction of Th2 responses and differential regulation of IL-12 and IL-23 synthesis. J Gene Med 7(7):869\u2013877. https:\/\/doi.org\/10.1002\/jgm.730","journal-title":"J Gene Med"},{"issue":"11","key":"9_CR66","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1172\/JCI119822","volume":"100","author":"JL Schultze","year":"1997","unstructured":"Schultze JL, Michalak S, Seamon MJ, Dranoff G, Jung K, Daley J, Delgado JC, Gribben JG, Nadler LM (1997) CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest 100(11):2757\u20132765. https:\/\/doi.org\/10.1172\/JCI119822","journal-title":"J Clin Invest"},{"issue":"7","key":"9_CR67","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.4049\/jimmunol.1800206","volume":"201","author":"SH Taitano","year":"2018","unstructured":"Taitano SH, van der Vlugt L, Shea MM, Yang J, Lukacs NW, Lundy SK (2018) Differential influence on regulatory B cells by TH2 cytokines affects protection in allergic airway disease. J Immunol 201(7):1865\u20131874. https:\/\/doi.org\/10.4049\/jimmunol.1800206","journal-title":"J Immunol"},{"key":"9_CR68","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fimmu.2014.00144","volume":"5","author":"MW Klinker","year":"2014","unstructured":"Klinker MW, Lizzio V, Reed TJ, Fox DA, Lundy SK (2014) Human B cell-derived Lymphoblastoid cell lines constitutively produce Fas ligand and secrete MHCII(+)FasL(+) killer Exosomes. Front Immunol 5:144. https:\/\/doi.org\/10.3389\/fimmu.2014.00144","journal-title":"Front Immunol"},{"issue":"7","key":"9_CR69","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/ni0706-681","volume":"7","author":"LA Herzenberg","year":"2006","unstructured":"Herzenberg LA, Tung J, Moore WA, Herzenberg LA, Parks DR (2006) Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol 7(7):681\u2013685. https:\/\/doi.org\/10.1038\/ni0706-681","journal-title":"Nat Immunol"}],"container-title":["Methods in Molecular Biology","Regulatory B Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1237-8_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T14:31:20Z","timestamp":1674916280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1237-8_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9781071612361","9781071612378"],"references-count":69,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1237-8_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"22 January 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}